SC
BIIB icon

Sepio Capital’s Biogen BIIB Stock Holding History

Sepio Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,788
Closed -$2.2M – 330
2022
Q2 		$2.2M Buy
10,788
+1,672
+18% +$342K 0.22% 128
2022
Q1 		$1.92M Buy
9,116
+374
+4% +$81.3K 0.17% 153
2021
Q4 		$2.1M Buy
+8,742
New +$2.25M 0.15% 172
2021
Q2 		– Sell
-3,407
Closed -$953K – 351
2021
Q1 		$953K Buy
+3,407
New +$919K 0.09% 224
2020
Q4 		– Sell
-854
Closed -$242K – 351
2020
Q3 		$242K Sell
854
-926
-52% -$258K 0.03% 315
2020
Q2 		$476K Sell
1,780
-126
-7% -$37.9K 0.06% 223
2020
Q1 		$603K Buy
1,906
+538
+39% +$163K 0.08% 157
2019
Q4 		$406K Buy
+1,368
New +$380K 0.04% 231

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sepio Capital's BIIB Position: Q3 2022 in Review

Sepio Capital sold out of Biogen (BIIB) in Q3 2022, closing a stake of 10,788 shares — an estimated $2.2M sold.

Sepio Capital first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $2.2M in Q2 2022. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Sepio Capital reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Sepio Capital sold 10,788 Biogen shares in Q3 2022, an estimated $2.2M.
  • Sepio Capital first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
  • Sepio Capital's Biogen position peaked at $2.2M in Q2 2022.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Sepio Capital's 13F filing for Q3 2022, filed 28 Oct 2022.